Identification of 2-(4-Pyridyl)Thienopyridinones as Gsk-3Beta Inhibitors.
Gentile, G., Bernasconi, G., Pozzan, A., Merlo, G., Marzorati, P., Bamborough, P., Bax, B., Bridges, A., Brough, C., Carter, P., Cutler, G., Neu, M., Takada, M.(2011) Bioorg Med Chem Lett 21: 4823
- PubMed: 21764580 
- DOI: https://doi.org/10.1016/j.bmcl.2011.06.050
- Primary Citation of Related Structures:  
3ZRK, 3ZRL, 3ZRM - PubMed Abstract: 
The discovery of a novel series of 2-(4-pyridyl)thienopyridinone GSK-3β inhibitors is reported. X-ray crystallography reveals its binding mode and enables rationalization of the SAR. The initial optimization of the template for improved cellular activity and predicted CNS penetration is also presented.
- Department of Medicinal Chemistry, Neuroscience Centre of Excellence of Drug Discovery, GlaxoSmithKline, Via A Fleming 4, 37135 Verona, Italy. gabriella.gentile@aptuit.com
Organizational Affiliation: